Venus Concept Australian Regulatory Approval for NeoGraft 2.0

Venus Concept Inc. Announces CE Mark and Australian Regulatory Approval for NeoGraft 2.0, A Trusted Name in Hair Restoration

Venus Concept Inc, a global medical aesthetic technology leader, today announced that it has received a CE Mark from DEKRA Certification B.V. and Therapeutic Goods Administration (TGA) clearance in Australia to market NeoGraft 2.0 for hair restoration.

NeoGraft 2.0 is intended as an automated hair transplant device using the Follicular Unit Extraction (FUE) method of harvesting and implanting hair follicles.

With the introduction of NeoGraft 2.0, Venus Concept has eliminated the inefficiencies of manual extractions and implants and replaced it with advanced technology that provides patients with the benefits of the FUE procedure, while also enabling physicians to benefit from easier transplants that yield superior clinical results.

The NeoGraft® 2.0 is a next generation version which offers an extended and double-jointed arm, updated implant and extraction tools, a pneumatic motor, and touchscreen interface, which together offer clinicians a more efficient treatment room and more consistent clinical outcomes. NeoGraft 2.0 procedures are minimally invasive, require less recovery time, and offer natural-looking results for all hair types, males and females alike.

“We launched NeoGraft 2.0 on a limited basis in Europe and Australia in the fourth quarter and look forward to a full commercial launch in these markets in the first quarter of 2020,” said Dom Serafino, Chief Executive Officer and Director of Venus Concept Inc. “Our recent merger with Restoration Robotics allows us to offer an end-to-end portfolio of minimally invasive solutions unique from any competitor in the hair restoration market today with ARTAS iX and NeoGraft 2.0.

With more than 600,000 procedures and an estimated $4 billion1 spent annually in global hair restoration, our portfolio of unique technology solutions, combined with our large global selling infrastructure, positions us well to drive growth in an extremely attractive global hair restoration market.”

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic technologies and reach in over 60 countries and 29 direct markets.

Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, and Venus Bliss. Venus Concept’s hair restoration division includes NeoGraft, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX™ Robotic Hair Restoration Systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms.

Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.

Venus Concept Inc. Announces CE Mark and Australian Regulatory Approval for NeoGraft 2.0, A Trusted Name in Hair Restoration


Previous Posts